Treatment of infantile haemangiomas: recommendations of a European expert group
Top Cited Papers
- 29 May 2015
- journal article
- review article
- Published by Springer Science and Business Media LLC in European Journal of Pediatrics
- Vol. 174 (7), 855-865
- https://doi.org/10.1007/s00431-015-2570-0
Abstract
With a prevalence of 2.6–4.5 %, infantile haemangiomas (IH) represent the most common tumour of infancy. While the majority of IH does not require therapy and regresses spontaneously, about 10 % of IH exhibit complications such as obstruction, ulceration or disfigurement. With the advent of oral propranolol, many conventional treatment options have become obsolete. This paper summarizes current recommendations for management of complicated IH. These recommendations have been written by an expert group after a consensus process including bibliographic review, several drafts of synthesis, meetings with quantitative voting system and redaction of an approved final manuscript. Conclusion: Oral propranolol is the first-line agent for the treatment of complicated IH. What is Known: • Infantile haemangiomas (IH) are the most common tumours of infancy. Within a very short period after its discovery and long before the publication of randomized controlled trials, propranolol has become the number one agent for the treatment of complicated IH. What is New: • We report IH treatment recommendations of an international, interdisciplinary team of experts, based on an up-to-date review of the literature. What is Known: • Infantile haemangiomas (IH) are the most common tumours of infancy. Within a very short period after its discovery and long before the publication of randomized controlled trials, propranolol has become the number one agent for the treatment of complicated IH. What is New: • We report IH treatment recommendations of an international, interdisciplinary team of experts, based on an up-to-date review of the literature.Keywords
This publication has 58 references indexed in Scilit:
- Blood Pressure Monitoring During the Induction and Maintenance Period of Propranolol Therapy for Complicated Infantile Hemangiomas: A Prospective Study of 109 InfantsPediatric Dermatology, 2015
- Propranolol and prednisolone combination for the treatment of segmental haemangioma in PHACES syndromeBritish Journal of Dermatology, 2015
- Atenolol versus propranolol for the treatment of infantile hemangiomas: A randomized controlled studyJournal of the American Academy of Dermatology, 2014
- Cardiac Screening in Infants with Infantile Hemangiomas before Propranolol TreatmentPediatric Dermatology, 2014
- Propranolol is more effective than pulsed dye laser and cryosurgery for infantile hemangiomasEuropean Journal of Pediatrics, 2013
- Multiple cutaneous infantile haemangiomas and the risk of internal haemangiomaBritish Journal of Dermatology, 2013
- Great Ormond Street Hospital treatment guidelines for use of propranolol in infantile isolated subglottic haemangiomaThe Journal of Laryngology & Otology, 2013
- A Randomized Controlled Trial of Propranolol for Infantile HemangiomasPublished by American Academy of Pediatrics (AAP) ,2011
- Characteristics of Infantile Hemangiomas as Clues to PathogenesisArchives of Dermatology, 2010
- Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangiomaNature Medicine, 2008